CIO Spotlight

CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors. Authors: M.J. Dattoli, S.M. Bravo, D.M. Kaplon, M. Hayes, A. Osorio, P.M. Dycus, D. Bostwick, J.M. Kaminski Why did you decide to study Feraheme (ferumoxytol), and what sets your… Read More
Timothy Clark, MD
Timothy Clark, MD, gives tips for conventional TACE in this Craftsman's Corner session from CIO.
Biopsy is the foundation of cancer care, but its importance is often understated. As the framework of precision medicine becomes more ingrained in the standard of care, interventional radiologists must remain well versed on the latest advances in biomarker science and be able to communicate with… Read More
Drs. Park and Haskal
by Auh Whan Park, MD, and Ziv Haskal, MD University of Virginia School of Medicine, Charlottesville, Virginia Although thyroid ablation is a common procedure in many countries around the world, it is offered less frequently in North America. A variety of physicians can perform thyroid ablation,… Read More
CIO abstracts 2018
CIO 2018 featured a variety of abstracts across the field of interventional oncology. View the PDFs to read  the abstracts and learn more about the research presented at CIO.
CIO included several featured abstracts, and we had the opportunity to talk in more detail with the authors. Abstract authors: E. Fayazzadeh, A.H. Amer, F. Aucejo, G. McLennan What sparked your interest in comparing outcomes of conventional transarterial chemoembolization (cTACE) and TACE using… Read More
packed hall
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused attention on lung, thyroid, and lymph nodes, as well as… Read More
CIO Day 1 Session 2
By Brenda Silva The CIO Townhall session provided an assessment of the value placed on recent trials and data that may affect interventional oncology practices and procedures. The discussion served to underscore the importance of interventional oncology (IO), make sense of conflicting trial… Read More
CIO Panel
By Brenda Silva As the 10th Annual Symposium on Clinical Interventional Oncology gets underway, the first session addressed the latest developments in hepatocellular carcinoma (HCC) treatments and therapy options. Course Director Shaun Samuels, MD, began with an observation about the mature status… Read More
Stephen Solomon, MD
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen Solomon, MD, reviews recently published trials, looks… Read More